Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

Novel Hormonal Agents Foster New Approaches in Nonmetastatic CRPC

Nonmetastatic castration-resistant prostate cancer is a more recently defined clinical state of prostate cancer, for which several approved drugs are now available.
Read More >>

PARP Investigations Continue on Path Toward Precision Medicine in Prostate Cancer

Darolutamide Approved in Europe for Nonmetastatic CRPC

Familial History of Prostate Cancer Strongly Linked With Early-Onset Disease

Stereotactic Ablative Radiation Slows Progression in Oligometastatic Prostate Cancer

Long-Term Follow-Up Validates Noninferiority Between Radiation Regimens in Prostate Cancer

View More Stories >>

View Conference Coverage

2020 SGO Annual Meeting

2020 School of Gastrointestinal Oncology

2020 New York GU

2020 Miami Breast Cancer Conference

2020 HCC-TAG Conference

Dr. Gomella on Potential Impact of Targeted Therapy Approvals on Genetic Testing in Prostate Cancer

Dr. Oh on Results From the PRINT Trial in mCRPC

Dr. Sartor on Implications of PSMA-PET Positivity in Prostate Cancer

Dr. de Wit on the AEs With Cabazitaxel in the CARD Trial in mCRPC

Dr. Hussain on the Implications of the PROfound Trial in mCRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Ep. 2: Identifying and Monitoring Testosterone Levels in CSPC

Ep. 1: Initiating Therapy for CSPC

Final Thoughts on Evolving Treatment of Prostate Cancer

Optimal Timing for Radium-223 With AR-Targeted Therapy

CARD: Sequencing Therapies in Metastatic Prostate Cancer

Role of Biomarkers in Metastatic Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Treatment Landscape of Castrate-Resistant Prostate Cancer

Hormone-Sensitive Prostate Cancer

Metastatic CSPC: Toxicity Management & Future Treatment

The Role of Enzalutamide in Treating Metastatic CSPC

The Approval of Apalutamide for Metastatic CSPC

The STAMPEDE Trial Long Term Follow-Up Data

The Future of Nonmetastatic CRPC Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

The Emerging Role of Chemotherapy in Metastatic Prostate Cancer